CATEGORIES

© Copyright 2004; Hanoitimes - Economic and Urban Newspaper;

The tribune of Hanoi People’s Committee

Publication Permit: 29/GP-CBC

Editor - in - Chief: Nguyen Thanh Loi

Managing Editor: Ta Thu Giang

Email : thugiang@hanoitimes.vn

Head Office: 21 Huynh Thuc Khang Street, Dong Da District, Hanoi

Branch Office: 221 Tran Phu Street, Ha Dong District, Hanoi

WORDS ON THE STREET 70th anniversary of Hanoi's Liberation Day Vietnam - Asia 2023 Smart City Summit Hanoi celebrates 15 years of administrative boundary adjustment 12th Vietnam-France decentrialized cooperation conference 31st Sea Games - Vietnam 2021 Covid-19 Pandemic
Home / Investment / News
Japan Taisho Group increases holding in Vietnam DHG Pharmaceutical to 32%
Ngoc Mai 06:18, 2018/08/22
DHG`s largest shareholder is State Capital Investment Corporation (SCIC) with 56.6 million shares or 43.31% of the medicine maker`s charter capital.
Japan-based Taisho Pharmaceutical completed the purchase of 9.2 million shares at DHG Pharmaceutical (DHG), increasing its stake at the latter to 32% or 41.8 million shares, Taisho said in a filing to the Ho Chi Minh City Stock Exchange (HoSE).
 
Illustrative photo.
Illustrative photo.
Before the deal, the Japanese group owned over 32.6 million shares of the Vietnamese firm or a 24.94% stake.

With a public offer of VND120,000 (US$5.20) apiece, Taisho Pharmaceutical was calculated to have spent over VND1.1 trillion (US$47.25 million) to increase its holding in DHG. 

Taisho Pharmaceutical in early June spent VND85.5 billion (US$3.71 million) for 650,000 shares of DHG, raising its holding in the Vietnamese medicine producer to 24.94%. 

DHG's largest shareholder is State Capital Investment Corporation (SCIC) with 56.6 million shares or a 43.31% stake.

On July 4, DHG Pharmaceutical's foreign ownership limit was removed, as a result, the company adjusted its targets of revenue and pre-tax profit growth of at least 13% and 7%, respectively. 

At the close on August 20, DHG's share value declined for a fifth straight day, touching to VND96,000 (US$4.13) per share. The stock stayed still on August 21.

Taisho Pharmaceuticals, headquartered in Tokyo, is a leading Japanese pharmaceutical company specializing in the manufacturing of pharmaceutical products and non-prescription dietary supplements under well-known brands.
Comments
Other news
14:43, 2024/11/18
Aircraft manufacturer Embraer seeks comprehensive aviation partnership with Vietnam
The Vietnamese leader urges the aircraft manufacturer to collaborate on technology transfer, airport construction and operation, research, and investment in Vietnam.
21:55, 2024/10/22
Better links with FDI firms to support Hanoi businesses
Hanoi will continue to focus on quality projects, especially with partners such as Japan, the United States, and Europe to boost technology transfer.
15:24, 2024/09/24
Vietnam calls for more US investment in innovation, hi-tech
The Vietnamese leader called on relevant agencies to resolve any challenges faced by investors and enhance the investment climate to encourage greater US investment in Vietnam.
14:13, 2024/09/23
Vietnamese leader urges Boeing to build production facility in Vietnam
Boeing is committed to continuing to support the development of Vietnam's aviation ecosystem, focusing on aviation infrastructure, human resources training, airport construction, and aircraft maintenance facilities.
14:38, 2024/09/17
Foreign capital pouring into Vietnam's real estate market
Experts are optimistic that the 2024 Land Law, once enacted, will help resolve legal bottlenecks and attract more FDI.
16:27, 2024/08/24
Vietnam news in brief - August 24
Read The Hanoi Times to stay up to date on developments in Vietnam.